<SEC-DOCUMENT>0001104659-25-106487.txt : 20251104
<SEC-HEADER>0001104659-25-106487.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104184444
ACCESSION NUMBER:		0001104659-25-106487
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coherus Oncology, Inc.
		CENTRAL INDEX KEY:			0001512762
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				273615821
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88402
		FILM NUMBER:		251451135

	BUSINESS ADDRESS:	
		STREET 1:		C/O DENNIS M. LANFEAR
		STREET 2:		333 TWIN DOLPHIN DR, SUITE 600
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		(650) 649-3530

	MAIL ADDRESS:	
		STREET 1:		C/O DENNIS M. LANFEAR
		STREET 2:		333 TWIN DOLPHIN DR, SUITE 600
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Coherus BioSciences, Inc.
		DATE OF NAME CHANGE:	20130114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioGenerics, Inc.
		DATE OF NAME CHANGE:	20110210

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bering Partners II, L.P.
		CENTRAL INDEX KEY:			0001811512
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		ONE MARITIME PLAZA
		STREET 2:		SUITE 2250
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		650-387-5779

	MAIL ADDRESS:	
		STREET 1:		ONE MARITIME PLAZA
		STREET 2:		SUITE 2250
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Bering Partners II, L.P. -->
          <cik>0001811512</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/05/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001512762</issuerCik>
        <issuerName>Coherus Oncology, Inc.</issuerName>
        <issuerCusip>19249H103</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>333 Twin Dolphin Drive, Suite 600</com:street1>
          <com:city>Redwood City</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94065</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bering Partners II, L.P. ("Bering II")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4763062.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4763062.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4763062.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.1</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>(1) 4,763,062 shares, except that Bering Partners II GP, L.L.C., the general partner of Bering II ("Bering II GP"), may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Bering II and Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer"), the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

(2) Includes (i) 4,763,062 shares of Common Stock held by Bering II and based on 116,227,275 shares of the Issuer's Common Stock outstanding as of July 31, 2025 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended June 30, 2025.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Common Stock only.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bering Partners II GP, L.L.C. ("Bering II GP")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4763062.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4763062.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4763062.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.1</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>(1) 4,763,062 shares, of which all are directly owned by Bering II.  Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares.  Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

(2) Includes (i) 4,763,062 shares of Common Stock held by Bering II and based on 116,227,275 shares of the Issuer's Common Stock outstanding as of July 31, 2025 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended June 30, 2025.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Common Stock only.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bering Partners III, L.P. ("Bering III")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2826446.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2826446.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2826446.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>2.4</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>(1) 2,826,446  shares, except that Bering Partners III GP, L.L.C., the general partner of Bering III ("Bering III GP"), may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Bering III and Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer"), the managing members of Bering III GP, may be deemed to have shared power to vote these shares.

(2) Includes (i) 2,826,446 shares of Common Stock held by Bering III and (ii) 1,274,623 shares of Common Stock issuable upon exercise of a warrant to purchase shares of Common Stock (the "Warrant") held by Bering III, and based on 116,227,275 shares of the Issuer's Common Stock outstanding as of July 31, 2025 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended June 30, 2025.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Common Stock only (assuming conversion of the  1,274,623 of shares attributable to the remaining exercisable warrant held by Bering III GP as of October 21, 2025).</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bering Partners III GP, L.L.C. ("Bering III GP")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2826446.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2826446.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2826446.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>2.4</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>(1) 2,826,446 shares, except that Bering Partners III GP, L.L.C., the general partner of Bering III ("Bering III GP"), may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Bering III and Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer"), the managing members of Bering III GP, may be deemed to have shared power to vote these shares.

(2) Includes (i) 2,826,446  shares of Common Stock held by Bering III and (ii) 1,274,623 shares of Common Stock issuable upon exercise of a warrant to purchase shares of Common Stock (the "Warrant") held by Bering III, and based on 116,227,275 shares of the Issuer's Common Stock outstanding as of July 31, 2025 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended June 30, 2025.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Common Stock only (assuming conversion of the  1,274,623 of shares attributable to the remaining exercisable warrant held by Bering III GP as of October 21, 2025).</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Evgeny Zaytsev ("Zaytsev")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>13200.00</soleVotingPower>
        <sharedVotingPower>7589508.00</sharedVotingPower>
        <soleDispositivePower>13200.00</soleDispositivePower>
        <sharedDispositivePower>7589508.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>7602708.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.5</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) 7,602,708 shares, of which 4,763,062 are directly owned by Bering II, 2,826,446 are directly owned by Bering III and 13,200 are directly owned by Zaytsev.  Bering II GP, the general partner of Bering II, and Bering III GP, the general partner of Bering III, may each be deemed to have sole power to vote the shares of Bering II and Bering III, respectively, and Zaytsev and Sawyer, the managing members of Bering II GP and Bering III GP, may be deemed to have shared power to vote these shares.

(2) Includes  7,602,708 shares of Common Stock, of which 4,763,062 are directly owned by Bering II, 2,826,446 are directly owned by Bering III, 13,200 are directly owned by Zaytsev and 1,274,623 shares of Common Stock issuable upon exercise of a warrant to purchase shares of Common Stock (the "Warrant") held by Bering III, and based on 116,227,275 shares of the Issuer's Common Stock outstanding as of July 31, 2025 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended June 30, 2025.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Common Stock only (assuming conversion of the 1,274,623 of shares attributable to the remaining exercisable warrant held by Bering III GP as of October 21, 2025).</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Philip Sawyer ("Sawyer")</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>7589508.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>7589508.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>7589508.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.5</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) 7,589,508 shares, of which 4,763,062 are directly owned by Bering II, 2,826,446 are directly owned by Bering III.  Bering II GP, the general partner of Bering II, and Bering III GP, the general partner of Bering III, may each be deemed to have sole power to vote the shares of Bering II and Bering III, respectively, and Zaytsev and Sawyer, the managing members of Bering II GP and Bering III GP, may be deemed to have shared power to vote these shares.

(2) Includes 7,589,508 shares of Common Stock, of which 4,763,062 are directly owned by Bering II, 2,826,446 are directly owned by Bering III and 1,274,623 shares of Common Stock issuable upon exercise of a warrant to purchase shares of Common Stock (the "Warrant") held by Bering III, and based on 116,227,275 shares of the Issuer's Common Stock outstanding as of July 31, 2025 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended June 30, 2025.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Common Stock only (assuming conversion of the 1,274,623 of shares attributable to the remaining exercisable warrant held by Bering III GP as of October 21, 2025).</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Coherus Oncology, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>333 Twin Dolphin Drive, Suite 600 Redwood City, CA, 94065</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Statement is filed by Bering Partners II, L.P. ("Bering II"), Bering Partners II GP, L.L.C., a Delaware limited liability company ("Bering II GP"), Bering Partners III, L.P. ("Bering III"), Bering Partners III GP, L.L.C., a Delaware limited liability company ("Bering III GP"), Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer").  The foregoing entities and individuals are collectively referred to as the "Reporting Persons."

Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote and sole power to dispose of shares of the issuer directly owned by Bering II.

Bering III GP, the general partner of Bering III, may be deemed to have sole power to vote and sole power to dispose of shares of the issuer directly owned by Bering III.

Zaytsev and Sawyer are managing members of Bering II GP and may be deemed to have shared power to vote and shared power to dispose of shares of the issuer directly owned by Bering II.

Zaytsev and Sawyer are managing members of Bering III GP and may be deemed to have shared power to vote and shared power to dispose of shares of the issuer directly owned by Bering III.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Bering Capital

601 California Street, Suite 620

San Francisco, CA 94108</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Bering II is a Delaware limited partnership.  Bering II GP is a Delaware limited liability company.  Bering III is a Delaware limited partnership.  Bering III GP is a Delaware limited liability company.  Zaytsev and Sawyer are United States citizens.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See Row 9 of cover page for each Reporting Person</amountBeneficiallyOwned>
        <classPercent>See Row 11 of cover page for each Reporting Person</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See Row 5 of cover page for each Reporting Person</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See Row 6 of cover page for each Reporting Person</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See Row 7 of cover page for each Reporting Person</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See Row 8 of cover page for each Reporting Person</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>Under certain circumstances set forth in the limited partnership agreement of Bering II, the limited partnership agreement of Bering III, the limited liability company agreement of Bering II GP, and the limited liability company agreement of Bering III GP, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a partner or member, as the case may be.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Bering Partners II, L.P. ("Bering II")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Managing Member of the General Partner</title>
        <date>11/03/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Bering Partners II GP, L.L.C. ("Bering II GP")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Managing Member</title>
        <date>11/03/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Bering Partners III, L.P. ("Bering III")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Managing Member of the General Partner</title>
        <date>11/03/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Bering Partners III GP, L.L.C. ("Bering III GP")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Managing Member</title>
        <date>11/03/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Evgeny Zaytsev ("Zaytsev")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Evgeny Zaytsev</signature>
        <title>Evgeny Zaytsev</title>
        <date>11/03/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Philip Sawyer ("Sawyer")</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Philip Sawyer</signature>
        <title>Philip Sawyer</title>
        <date>11/03/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
